Tag: biotech

May 1, 2024, St. Petersburg, FL—Water Tower Research LLC (www.watertowerresearch.com) is modernizing IR with a powerfully differentiated ecosystem of investor relations services, research-driven content and communications, and investor engagement. Water Tower Research is pleased to announce that Do Kim will […]

April 26, 2023, ST. PETERSBURG, FL – Water Tower Research (www.watertowerresearch.com) has published an Initiation of Coverage Report on InMed Pharmaceuticals, Inc. (NASDAQ: INM) titled, “A Unique Developer of Rare Cannabinoid-Based Therapies”. The report can be accessed here. Vancouver-headquartered and […]

April 20, 2023, St. Petersburg, Florida – Water Tower Research LLC (www.watertowerresearch.com), is modernizing Investor Relations through research-driven communication and investor engagement. WTR is pleased to announce that Sally Yanchus has joined the firm as Senior Research Analyst of Life Sciences. […]

September 29, 2022, ST. PETERSBURG, FL – Water Tower Research (www.watertowerresearch.com) has published an Initiation of Coverage Report on Numinus Wellness, Inc. titled, “An End-to-End Mental Health Service Company”. The report can be accessed here. Established in 2019, Canada-based Numinus […]

Sydney, 20 July 2022 – Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is lending its support to Glioblastoma (GBM) Awareness Day 2022 and remains firmly focused on developing a treatment that may help improve the […]

Orlando, Florida, June 02, 2021 — Immune Therapeutics Inc. (OTC-PINK: IMUND) (the “Company”) announced today that the Company has received and signed a non-binding term sheet to enter into an agreement that would provide working capital and wipe out a […]

The Fireside Chat will take place on Wednesday, February 10th at 2:00 pm Eastern Time. The live event will also be archived and available for replay. The Fireside Chat is open for all investors to access. “We are excited to […]

Support for preclinical testing for a novel broad spectrum inhaled anti-infective that rapidly eradicates microbial biofilms which are present in the lungs of Cystic Fibrosis patients DUBLIN,OHIO (26 January 2021) Kinnear Pharmaceuticals (Kinnear)announces an agreement with the Cystic Fibrosis Foundation […]

DENVER, Colo., July 27, 2020- Moderna (NASDAQ:MRNA) was the weekend’s big Corona winner, as the U.S. government adjusted its existing contract, by increasing funding, by up to $472 million, for a “significantly” larger Phase 3 study of the company’s COVID-19 […]

Responses From More Than 400 Attorneys and Experts Illuminate Trends Pensacola, Fla.  |   IMS ExpertServices announced it will reveal the top trends and findings from a recent survey of more than 400 commercial litigation industry stakeholders during a live Analysts’ […]

The National Law Journal Awards IMS ExpertServices with Recognition Across Unprecedented Six “Best Of” Categories Following the Firm’s Recent Alliance with The Focal Point Scope of National Awards Confirms Union Between IMS ExpertServices and The Focal Point Successfully Delivering Unparalleled […]

Nation’s Leading Expert Services Firm Joins with Respected End-to-End Litigation Consultancy IMS Will Bring Deeper Services and Exclusive Offerings to AmLaw 250 Clients   Pensacola, FL | IMS, the award-winning expert services firm, announced today that it has partnered with […]